SR 26-2 model risk examination with SWT3 witness anchor citations. Traditional MRM sections plus GenAI governance gap analysis.
Targeted Model Risk Examination Report
AI/ML Model Portfolio -- Governance, Validation, and Monitoring
Institution: Commonwealth National Bank
Charter Type: National Bank (OCC-supervised)
Model Portfolio: 23 AI/ML models (credit, fraud, AML, pricing)
GenAI Models in Scope: 4 (customer service, document summarization, risk narrative, code review)
Examination Authority: Office of the Comptroller of the Currency
Examination Team: CNB-2026-Q3
Supervisory Framework: OCC SR 26-2 (Model Risk Management for AI/ML)
Report Date: 2026-10-08
Examination Window: 2026-07-01 through 2026-09-30 (92 days)
This targeted examination evaluates Commonwealth National Bank's model risk management practices for its AI/ML model portfolio under OCC SR 26-2. The examination covers traditional model risk management (governance, inventory, validation, monitoring, outcomes analysis) and extends to GenAI-specific governance practices including third-party model risk, concentration risk, and explainability.
The institution operates 23 AI/ML models: 12 credit scoring, 4 fraud detection, 3 AML/BSA, and 4 GenAI applications. The 4 GenAI models were added in 2026 and represent the institution's first deployment of large language model technology in production.
2 Matters Requiring Attention (MRAs). No Matters Requiring Immediate Attention (MRIAs). Traditional MRM practices are satisfactory. GenAI governance requires attention in two areas: independent validation of GenAI models and vendor concentration risk documentation.
| Metric | Value |
|---|---|
| Procedures Assessed | 12 |
| Satisfactory | 10 |
| MRAs Issued | 2 |
| MRIAs Issued | 0 |
| Models in Portfolio | 23 (19 traditional ML + 4 GenAI) |
| SWT3 Anchors Verified | 18 (5 independently recomputed) |
| Examination Window | 2026-07-01 through 2026-09-30 (92 days) |
This examination was conducted per OCC examination procedures aligned with SR 26-2 (Model Risk Management for AI/ML), which supersedes SR 11-7 for AI/ML model portfolios. SR 26-2 is explicitly non-binding supervisory guidance. Examination findings are supervisory assessments, not regulatory mandates.
sovereign.tenova.io/verify. All returned VALID.The examination window (92 days) covers Q3 2026 operating activity. SWT3 evidence supplements traditional examination artifacts (committee minutes, validation reports, model performance dashboards). Of 12 procedures assessed, 10 had continuous coverage. Two gaps documented below.
The examination assessed both traditional ML models (established MRM practices) and GenAI models (newer, with distinct risk characteristics including non-determinism, third-party dependency, and limited explainability). SR 26-2 Section IX specifically addresses generative AI governance, which this examination evaluates.
| Procedure | Anchor | Verified | Witness Date |
|---|---|---|---|
| FIN-GOV.1 (Committee Approval) | SWT3-E-VULTR-AI-FINGOV1-PASS-1790841600-c4e8f2a1b736 |
VALID (recomputed) | 2026-09-28 |
| AI-GOV.1 (Governance Attestation) | SWT3-E-VULTR-AI-AIGOV1-PASS-1790755200-a7d3e1f9c284 |
VALID | 2026-09-27 |
Supplementary evidence: Committee minutes (Q1-Q3 2026) reviewed. Interview with Committee Chair (CNB-INT-Q3-04) confirmed quorum met at all 3 quarterly meetings. Voting records show unanimous approval for new model deployments.
| Procedure | Anchor | Verified | Witness Date |
|---|---|---|---|
| FIN-MRM.1 (Model Inventory) | SWT3-E-VULTR-AI-FINMRM1-PASS-1790668800-b8c2f4a7e163 |
VALID (recomputed) | 2026-09-26 |
Supplementary evidence: Model registry reviewed. All 23 models have complete inventory records. GenAI models include additional fields for vendor, API version, and prompt template versioning.
| Procedure | Anchor | Verified | Witness Date |
|---|---|---|---|
| FIN-VAL.1 (Independent Validation) | SWT3-E-VULTR-AI-FINVAL1-PASS-1790582400-d1e5f9a3c782 |
VALID | 2026-09-25 |
Examiner assessment: FIN-VAL.1 anchor confirms independent validation is operational for the traditional ML portfolio. The absence of GenAI validation is a documented gap. The institution's plan to develop a GenAI validation framework is acknowledged but does not constitute completed validation. SR 26-2 Section VI requires independent validation for all models in production, including GenAI applications.
Required action: Complete independent validation of all 4 GenAI models using appropriate methodologies (output quality assessment, adversarial testing, hallucination rate measurement, prompt injection testing). Deadline: 90 days (2027-01-06).
| Procedure | Anchor | Verified | Witness Date |
|---|---|---|---|
| FIN-MON.1 (Performance Monitoring) | SWT3-E-VULTR-AI-FINMON1-PASS-1790496000-a9c4e7f1b258 |
VALID | 2026-09-24 |
| AI-DRIFT.1 (Drift Detection) | SWT3-E-VULTR-AI-AIDRIFT1-PASS-1790409600-f3a7c9e1b452 |
VALID (recomputed) | 2026-09-23 |
Supplementary evidence: Performance dashboards reviewed during examination. All traditional ML models within PSI/CSI thresholds. GenAI drift monitoring shows stable output quality over the examination window.
| Procedure | Anchor | Verified | Witness Date |
|---|---|---|---|
| FIN-OUT.1 (Outcomes Analysis) | SWT3-E-VULTR-AI-FINOUT1-PASS-1790323200-b2f6c8d1e743 |
VALID | 2026-09-22 |
Examiner notes: Back-testing results for credit scoring models show predicted-vs-actual default rates within 15bps tolerance (approved threshold: 25bps). Fraud detection false positive rates stable at 2.1% (threshold: 3.0%).
SR 26-2 extends traditional MRM to address risks specific to generative AI: non-determinism, third-party model dependency, concentration risk, and limited explainability. This section assesses the institution's GenAI governance practices against these expanded expectations.
| Procedure | Anchor | Verified | Witness Date |
|---|---|---|---|
| AI-GRD.1 (Guardrail Enforcement) | SWT3-E-VULTR-AI-AIGRD1-PASS-1790236800-c6d8e2f4a193 |
VALID | 2026-09-21 |
| AI-EXPL.1 (Explainability) | SWT3-E-VULTR-AI-AIEXPL1-PASS-1790150400-e4f8a2c6b317 |
VALID (recomputed) | 2026-09-20 |
| AI-SUPPLY.1 (Third-Party Model Risk) | SWT3-E-VULTR-AI-AISUPPLY1-PASS-1790064000-a3b7c1d5e928 |
VALID | 2026-09-19 |
| AI-CHAIN.1 (Supply Chain Risk Mapping) | SWT3-E-VULTR-AI-AICHAIN1-PASS-1789977600-f1c4e7a9b263 |
VALID | 2026-09-18 |
| AI-HITL.1 (Human Oversight) | SWT3-E-VULTR-AI-AIHITL1-PASS-1789891200-d7e1f3a9c482 |
VALID | 2026-09-17 |
Examiner assessment: SWT3 evidence for AI-CHAIN.1 provided the vendor dependency data that surfaced the concentration risk. This evidence would not have been available through traditional document review alone -- the model inventory lists vendor names but does not aggregate dependency ratios or flag concentration thresholds. The SWT3 supply chain mapping enabled a quantitative assessment of vendor concentration that the institution's own risk management had not performed.
Required action: Update the risk appetite statement to include vendor concentration thresholds for AI/ML model dependencies. Document a contingency plan for single-vendor disruption scenarios covering the 14 affected models. Deadline: 60 days (2026-12-07).
| ID | SR 26-2 Section | Classification | Description | Deadline | Responsible |
|---|---|---|---|---|---|
| MRA-001 | VI (Validation) | MRA | Complete independent validation of 4 GenAI models using appropriate methodologies (output quality, adversarial testing, hallucination measurement, prompt injection testing). | 2027-01-06 | Head of Model Validation |
| MRA-002 | IX (GenAI Governance) | MRA | Update risk appetite statement with vendor concentration thresholds. Document contingency plan for single-vendor disruption covering 14 affected models. | 2026-12-07 | Chief Model Risk Officer |
| Category | Count | Validated | Monitored | Vendor Dependency |
|---|---|---|---|---|
| Credit Scoring | 12 | 12 | 12 | 8 in-house, 4 vendor API |
| Fraud Detection | 4 | 4 | 4 | 2 in-house, 2 vendor API |
| AML/BSA | 3 | 3 | 3 | 1 in-house, 2 vendor API |
| GenAI Applications | 4 | 0 | 4 | 4 vendor API (single vendor) |
| Total | 23 | 19 | 23 | 11 in-house, 12 vendor API |
Concentration analysis: 14 of 23 models (61%) depend on a single vendor's API infrastructure. All 4 GenAI models use the same vendor exclusively. This concentration exceeds the 40% threshold recommended in the institution's own vendor risk management framework (which had not been applied to AI model dependencies).
| Procedure | Anchor (Truncated) | Verification Method | Result | Verified On |
|---|---|---|---|---|
| FIN-GOV.1 | ...c4e8f2a1b736 | SHA-256 recomputation (OpenSSL 3.x) | MATCH | 2026-10-04 |
| FIN-MRM.1 | ...b8c2f4a7e163 | SHA-256 recomputation (OpenSSL 3.x) | MATCH | 2026-10-04 |
| AI-DRIFT.1 | ...f3a7c9e1b452 | SHA-256 recomputation (OpenSSL 3.x) | MATCH | 2026-10-04 |
| AI-EXPL.1 | ...e4f8a2c6b317 | SHA-256 recomputation (OpenSSL 3.x) | MATCH | 2026-10-04 |
| AI-CHAIN.1 | ...f1c4e7a9b263 | SHA-256 recomputation (OpenSSL 3.x) | MATCH | 2026-10-04 |
Remaining 13 anchors were verified via the public verifier at sovereign.tenova.io/verify. All returned VALID.
Examination Outcome: 2 MRAs, 0 MRIAs
Commonwealth National Bank's traditional model risk management practices are satisfactory and well-established. The institution's expansion into GenAI introduces risk categories (non-determinism, vendor concentration, limited validation methodologies) that require governance attention.
The examination team notes that SWT3 supply chain evidence (AI-CHAIN.1) provided quantitative vendor dependency data that surfaced a concentration risk the institution's own risk management had not identified. This demonstrates the value of cryptographic witness evidence as a supplementary examination tool for portfolio-level risk analysis.
MRA-001 and MRA-002 will be communicated to the institution via supervisory letter. Follow-up examination of both matters scheduled for Q1 2027.
SWT3 witness anchors cited in this report follow the format:
Any anchor can be independently verified at sovereign.tenova.io/verify with no account or authentication. The SHA-256 fingerprint formula is published in the SWT3 Protocol Specification.